Irene Jarchum

Suggest Changes
Learn More
volume 34 number 9 September 2016 nature biotechnology phase could provide durable prevention of B-cell autoantigen presentation. Thus, CAAR T cells that selectively target pathogenic(More)
volume 34 number 1 January 2016 nature biotechnology of Fc-related vaccine signatures, there are practical and methodological concerns that will have to be taken into consideration when undertaking(More)
VOLUME 36 NUMBER 7 JULy 2018 nature biotechnology Sensors that track our health could enable earlier disease detection and therapeutic intervention. Few applications are more intriguing than(More)